Introduction {#s1}
============

Inborn errors of immunity are a group of over 350 individually rare congenital diseases that result from mutations in one or more genes coding for proteins of the immune system. DNA repair defects result from mutations in any of several genes coding for proteins in a complex nuclear machinery that detect and fix double strand DNA breaks. Every cell in our body is exposed to 10 to 50 DNA double strand breaks per day, from intracellular mechanisms (meiosis, isotype class switch, gene recombination) and extracellular insults (free radicals, ionizing radiation, drugs) ([@B1]). In lymphocytes, a crucial process is the generation of diversity in T-cell receptors and immunoglobulins through V(D)J somatic recombination, which starts with the introduction of double strand breaks in the genes by RAG1 and RAG2 ([@B2]). Defects in the DNA repair machinery proteins (ATM, RAD50, NHEJ1, Artemis, NBN, SBDS, LIG4, MRE11, POLE) result in increased apoptosis, and oncogenesis. Most patients with DNA repair defects share a syndrome of neurologic deficits, combined (T and B-cell) immunodeficiency, bone marrow failure and/or hematologic neoplasia ([@B3]).

DNA Ligase IV is a 911-aminoacid protein, a nuclear enzyme with a DNA binding domain and two BRCT motifs, involved in double strand DNA repair through the non-homologous end-joining (NHEJ) pathway, the major repair mechanism in mammalian cells, which consists of at least 5 proteins. Specifically, the LIG4/XRCC4 complex oversees the final ligation step of the process (making ends of the repaired strands meet). Knockout models of the gene *LIG4*, located in human chromosome 13 and consisting of a single long exon, are lethal to mouse embryos because of massive neuronal apoptosis ([@B4]); all known human mutations are thus hypomorphic and result in a wide clinical spectrum, ranging from normal to severely compromised immune system with microcephaly, growth failure, facial dysmorphism, mental retardation, hypogonadism, progressive bone marrow failure, and leukemia or lymphoma. The physiopathology at a cellular level includes mutagenesis, apoptosis and oncogenesis, despite some residual function of LIG4, and despite a redundant DNA repair machinery. The resulting immune defect might be a radiosensitive T-B-NK+ severe-combined immunodeficiency. Even with a clinically normal phenotype, chances are that lymphocytes will have a restricted receptor repertoire, and that hematopoietic cells be susceptible to ionizing radiation and other insults, with cumulative DNA damage leading to bone marrow failure and hematologic malignancies ([@B5]).

Here, we describe five cases of DNA Ligase 4 deficiency (MIM phenotype number **\#606593**) in two unrelated families from Mexico, whose clinical presentations ranged from lymphoma and early death, to mild disease. We reviewed the literature to further document the varying clinical presentations.

Written informed consent was obtained from the parents of all patients, for the publication of this case series, and any potentially identifying information, including face pictures and family trees.

Case Reports {#s2}
============

Family A
--------

A one-year-old boy from Northern Mexico was referred to UMAE-25 to rule out primary immunodeficiency. The third of four siblings, he was born at term to non-consanguineous parents.

An elder brother had died of Non-Hodgkin lymphoma of the brain at age 18 months old. He received BCG vaccination at birth, in 2005. At age 4 months he was hospitalized for viral encephalitis, and at 12 months for pneumonia and sepsis, with positive Cytomegalovirus (CMV) viral load (2,020 copies/ml); he suffered recurrent upper respiratory, gastrointestinal, and urinary infections; he developed oral candidiasis and a perianal ulcer caused by *Pseudomonas spp*; laboratory workup showed anemia (Hb 8.13 g/dL) and thrombocytopenia (80,000 per microliter), with normal leukocyte numbers and serum immunoglobulin levels: IgG 760 mg/dL, IgM 49 mg/dL, IgA 83 mg/dL; flow cytometry of lymphocyte subsets reported low CD4+ (110 cells/μl) and CD8+ (307 cells/μl) T-cells, with 1982 B-cells (43%), and 130 NK cells (9%); HIV infection was ruled out. A bone marrow aspirate showed myeloid maturation arrest with dysplastic forms. He was admitted with neurologic decay, fever, and systemic inflammation shortly before his death. The autopsy confirmed a diffuse large B-cell Non-Hodgkin lymphoma. Immunohistochemical staining for Epstein-Barr virus (EBV) was not available.

A second sister died at age 9 months of lung lymphoma. She started at 4 months old, with three episodes of pneumonia and one of sepsis; she suffered from milk protein allergy, vulvovaginal candidiasis, and diaper area dermatitis; her laboratory workup found: transient peripheral lymphopenia, low T-cells subsets (CD4+ 8 to 403 cells/mm^3^, CD8+ 6 to 232/mm^3^) with normal B and NK cells; normal serum immunoglobulin levels (IgG 853mg/dL, IgM 41, IgA 64 mg/dL, IgE \< 18 IU/ml); positive CMV viral load, *Acinetobacter baumanii* cultured from blood, *Enterococcus faecium* from urine, and *Enterobacter aerogenes* from bronchial aspirate. Cystic fibrosis, HIV infection, tuberculosis, and gastroesophageal reflux disease were ruled out; a nitroblue tetrazolium (NBT) reduction assay was normal at 81%. The chest X-ray showed a paravertebral mediastinal mass; a chest computed tomography (CT) confirmed a well-delimited, right retrocardiac rounded mass shortly before her death. She deteriorated abruptly with metabolic acidosis, progressive respiratory distress and heart failure; she was admitted to the intensive care unit and received mechanical ventilation support, broad-spectrum antibiotic, milrinone, and cyclophosphamide, without improvement. The autopsy confirmed a diffuse large B-cell lymphoma; EBV staining was not performed.

Our patient, the third sibling, received the BCG vaccine at birth, without complications. Before 1 year of age he was treated for uncomplicated pharyngitis and avascular necrosis of the femoral head (Legg-Calvé-Perthes disease). Given his family history, he was started on oral trimethoprim/sulfamethoxazole (TMP/SMZ) and sent to our hospital for evaluation.

Other than an initially positive CMV viral load (440 copies/ml, age 1 year, treated with ganciclovir for 90 days), his first laboratory workup was unremarkable. A CT scan from head to abdomen was normal. Serum immunoglobulin levels and absolute lymphocyte counts were normal at age 1, 4, and 7 years old. In contrast, the CD4+ T-cell subset count has remained steadily low (163--657 cells/mm^3^, or 7--23%). The Mantoux tuberculin skin test was reactive at 11 mm of induration, at age 7 months. However, CFSE lymphocyte proliferation assay was low at age 9 months, and absent 3 years later, under: PMA/ionomycin, phytohemagglutinin, concanavalin, and anti-CD3/CD28 stimuli (Figure [3](#F3){ref-type="fig"}).

Whole-exome sequencing, performed at Texas Children\'s Hospital, revealed a compound heterozygous pathogenic variant (missense and small 5bp deletion) in *LIG4*: c.833G\>A (p.R278H)/c.1271_1275delAAAGA (p.K424RfsX20). The p.K424R variant encodes a truncated protein missing 482 aminoacids; its frequency is lower than 0.03% for all populations according to ExAc (exac.broadinstitute.org). The p.R278H variant is predicted to be deleterious by all: DANN, GERP, dbNSFP, FATHMM, LRT, MetaLR, MetaSVM, MutationAssessor, MutationTaster, and PROVEAN *in silico* predictors. Both variants have been previously reported in patients with LIG4 deficiency and predicted to be deleterious by both SIFT and PolyPhen (transcript NM_206937.1, LIG4base, [www.ensembl.org](http://www.ensembl.org)).

In time, the patient, now 6 years old, developed obesity with normal stature and head circumference (see Figure [1](#F1){ref-type="fig"}), and no other manifestation. A younger brother, born in 2017, is also asymptomatic, in apparent good health (Figure [2](#F2){ref-type="fig"}).

![**(A)** Short stature with overweight in normocephalic school-age boy. Contrast with **(B,C)** Facial dysmorphisms seen in two twin sisters with LIG4 deficiency. Note prominent middle third of the face, long nose, micrognathia, long ears, jaundice, protruding tongue. (Face photos published with permission from their mothers).](fped-06-00426-g0001){#F1}

![Family trees. In **Family A**, the elder siblings of the proband died young of lymphoma. The proband has a history of avascular necrosis of the femoral head, short stature and isolated CD4+ deficiency; his younger brother is asymptomatic. In **Family B**, teenage twin sisters died after a long history of recurrent infections, chronic liver disease, and progressive bone marrow failure (The pedigrees were built at pedigree.progenygenetics.com; they are included after written informed consent from the mothers).](fped-06-00426-g0002){#F2}

![Carboxyfluorescein succinimidyl ester lymphoproliferation assay, plot (**upper panel**), and indexes (**lower panel**).](fped-06-00426-g0003){#F3}

Family B
--------

Two teenage girl twins from Western Mexico were referred to INER for recurrent respiratory infections. They had a history of microcephaly and facial dysmorphism, with growth and psychomotor delay. Born pre-term (at 32 weeks of gestation) to non-consanguineous parents, the patients had three healthy elder siblings, and a pet dog.

During their first months of life, they suffered from 3 to 4 pneumoniae, gastroenteritis, and urinary tract infections. By 13 years of life, when they were referred to the National Institute of Pediatrics, they had developed moderate generalized jaundice with hepatosplenomegaly.

On physical examination, short stature (below percentile 10), low weight, mild to moderate mental retardation and speech delay were noted, with microcephaly below p3, a prominent mid-face with long nose, and micrognathia with a protruding tongue (see Figure [1](#F1){ref-type="fig"}). They had primary amenorrhea with absent secondary sexual features. A chest CT documented diffuse bilateral bronchiectasis; abdominal ultrasound and a barium swallow revealed portal hypertension with esophageal varices.

Laboratory workup showed persistent mild leukopenia with lymphopenia. Since around age twelve, they developed progressive pancytopenia: Hb 8g/dL, lymphocytes 210--300/mm^3^, less than 500 neutrophils, and 120,000 platelets; as well as elevated liver enzymes: increased conjugated bilirubin, ALT, AST, GGT, alkaline phosphatase, high ferritin (over 600 ng/ml), low fibrinogen (100 mg/dL), and high triglycerides (300 mg/dl). All serum immunoglobulins and lymphocyte subsets (CD3+, CD4+, CD8+, CD19+, CD16/56+) were also low: IgG 105--169 mg/dL, IgM 8.96--26.6 mg/dL, IgA \< 6.67 mg/dL, IgE 1.1--1.5 IU/mL. A bone marrow aspirate reported medullary aplasia. Cellular radiosensitivity (radiomimetic assay) was negative to bleomycin; serologic tests for HepA, HepB, HepC, CMV, and EBV came back negative. Liver biopsy reported portal fibrosis with perivascular cell infiltration, suggestive of obstructive cirrhosis.

A provisional diagnosis of Nijmegen breakage syndrome (NBS) with bone marrow failure and sclerosing cholangitis was given. They continued treatment with prophylactic antibiotics and monthly intravenous gammaglobulin (IVIG), as well as ursodeoxycholic acid, molgramostin (GM-CSF), and oral transfer factor (leukocyte dialysate). They died 2 years apart at ages 14 and 16, at their hometown hospital, one twin of sudden massive gastrointestinal bleeding, and the other of sepsis and multiorgan failure (with pneumonia, anuria, and a distended abdomen). No autopsy was performed.

*NBN* was amplified and sequenced in Berlin with no mutations found. Years later, a targeted exome panel (Illumina TruSight) performed at INMEGEN in Mexico, revealed a compound heterozygous mutation in *LIG4*, consisting of the same 5 base-pair deletion as that of family A (c.1271_1275delAAAGA) in allele 1 (p. K424RfsX20), and a missense point mutation (c.745A\>G) in allele 2 (p.M249V); both previously reported in patients with LIG4 deficiency (transcript NM_206937.1; LIG4base, [www.ensembl.org](http://www.ensembl.org)), and predicted to be deleterious/probably damaging by both SIFT and PolyPhen. The p.M249V variant is absent from population databases such as gnomAD exomes; it is also predicted to be deleterious/probably damaging by all: DANN, GERP, dbNSFP, FATHMM, LRT, MetaLR, MetaSVM, MutationAssessor, MutationTaster, and PROVEAN *in silico* predictors.

Review of the Literature {#s3}
========================

The first patient with LIG4 deficiency, a 14-year-old teenage boy with acute lymphoblastic leukemia who died 8 months after receiving prophylactic cranial radiotherapy, was characterized clinically in 1990 ([@B6]), and genetically in 1999 ([@B7]). Tables [1](#T1){ref-type="table"}--[3](#T3){ref-type="table"} summarize the clinical, laboratorial and genetic findings of all published patients available in PubMed Medline (<https://www.ncbi.nlm.nih.gov/pubmed/>) as of August 2018. Clinical and immunological manifestations vary widely, even among siblings with the same mutation. Table [4](#T4){ref-type="table"} summarizes the prevalence of neurological, developmental, infectious, and hematological components of LIG4 deficiency. The degree of protein truncation (early, mid, and late) seems to correlate with clinical, hematological, and immunological severity (mild, moderate, and severe).

###### 

Demographic and clinical features of published patients with LIG4 deficiency.

  **Patient**   **Origin**              **Sex**   **Family**                                                      **Age at dx (years)**   **Onset**                                            **Clinical features**                                                                                                                                                          **Status**                                                                                   **References**
  ------------- ----------------------- --------- --------------------------------------------------------------- ----------------------- ---------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------------- ------------------------
  1 (180BR)     Turkish-cypriot         Male                                                                      14                      B-symptoms                                           Weight loss, anorexia, lethargy, pallor, lymphadenopathy, hepatosplenomegaly: Acute lymphoblastic leukemia                                                                     Died 8 months after radiotherapy                                                             [@B6], [@B7]
  2             USA                     Fem                                                                       26                      Microcephaly and microsomy, lethargy and dizziness   Seckel syndrome. Cough, fever, pallor.                                                                                                                                         Died of pneumonia 2 months after chemotherapy                                                ([@B8])
  3 (411BR)     Germany                 Male                                                                      9                       Microcephaly                                         Dysmorphism, developmental delay and plantar warts.                                                                                                                            Died at age 23 of lymphoma                                                                   ([@B4], [@B9], [@B10])
  4 (2303)      USA                     Male      Sibling to 2304                                                 46                      Microcephaly                                         Chronic skin conditions, photosensitivity, telangiectasia, sinusitis                                                                                                           NR                                                                                           ([@B9])
  5 (2304)      USA                     Fem       Sibling to 2303                                                 48                      Microcephaly                                         Dysmorphism, growth failure, respiratory infections, psoriasis                                                                                                                 NR                                                                                           ([@B9])
  6 (99P0149)   Germany                 Fem       Non-consang.                                                    9                       Microcephaly                                         Dysmorphism, dwarfism, mental delay, psoriasis                                                                                                                                 Alive and well 5 years after RIC HSCT from HLA-identical brother                             ([@B9], [@B11])
  7 (3703)      Canada                  Male      First cousin died of brain tumor in early childhood             4.75                    Acute leukemia                                       Microcephaly, dysmorphism, developmental delay, hypogonadism, leukemia                                                                                                         Died shortly after chemotherapy                                                              ([@B12])
  8 (SC2)       Turkish                 Fem       Consang., heterozygous                                          1.5                     Respiratory infections                               Respiratory infections, candidiasis, chronic diarrhea, failure to thrive, fever                                                                                                Died after conditioning, possibly due to veno-occlusive disease.                             ([@B13])
  9 (P2)        German                  Fem       Sister to 10                                                    0                       Microcephaly                                         Alive after HSCT                                                                                                                                                               ([@B14])                                                                                     
  10 (P1)       German                  Fem       Sister to 9                                                     2                       Recurrent infections                                 Chronic diarrhea, recurrent infections, failure to thrive, autoimmune cytopenia                                                                                                Died shortly after chemotherapy                                                              ([@B14])
  11 (P-1)      Morocco                 Fem       Sister to 12                                                    1.5                     Repeated infections since 3 months old               Microcephaly, otitis, bronchiolitis, pneumonia and sepsis                                                                                                                      Died of EBV PTLD 50 days after HSCT                                                          ([@B2])
  12 (P-2)      Morocco                 Fem       Sister to 11                                                    0                       Microcephaly                                         Died of VOD 2 months after HSCT                                                                                                                                                ([@B2])                                                                                      
  13            Japan                   Fem                                                                       14                      Mouth tumor, fever                                   Microcephaly, short stature, polydactyly,                                                                                                                                      Died after chemotherapy                                                                      ([@B15])
  14            Canada                  Fem       Non-consang.                                                    0.1                     Omenn syndrome                                       Microcephaly, low weight, rash, hepatosplenomegaly, lymphadenopathy, diarrhea.                                                                                                 Alive and well 3.5 y after full conditioning HSCT                                            ([@B16])
  15            Turkish                 Fem       Consang., sister to 16                                          10                      Microcephaly, respiratory infections                 Sinopulmonary recurrent infections                                                                                                                                             Alive and well after 2 RIC HSCTs                                                             ([@B8])
  16            Turkish                 Male      Consang., brother to 15                                         6                       Ecchymoses                                           Low weight, upper respiratory and urinary infections                                                                                                                           Alive                                                                                        ([@B8])
  17 (F10)      Netherlands             Male                                                                      0.25                    Microcephaly, dysmaturity, dysmorphism               Feeding difficulties, diarrhea, failure to thrive, icterus, tubulopathy, erythema                                                                                              Died at 6 months of sepsis, respiratory insufficiency and severe gastrointestinal bleeding   ([@B17], [@B18])
  18            USA                     Fem                                                                       34                      Dubowitz syndrome                                    Rectorrhagia                                                                                                                                                                   Died of metastatic anal cancer                                                               ([@B18], [@B19])
  19 (F1.1)     Canada                  Fem       Sister to 20                                                    17.5                    Microcephaly                                         Small cerebral aneurysm, primary ovarian failure                                                                                                                               Alive                                                                                        ([@B18])
  20 (F1.2)     Canada                  Fem       Sister to 19                                                    11.75                   Microcephaly                                         Atrial-ventricular septal defect, atrofphic kidney, rib hypoplasia, fusion of carpal bones, copper beaten skull, platybasia, abnormal C1 vertebrae, primary ovarian failure.   Alive                                                                                        ([@B18])
  21 (F2)       USA                     Fem                                                                       7.8                     Microcephaly, malformations                          Anal atresia with rectovaginal fistula, esotropia.                                                                                                                             Alive                                                                                        ([@B18])
  22 (F3)       Australia               Fem                                                                       2.1                     Microcephaly, hip dysplasia                          Unilateral congenital hip dysplasia, cutis marmorata.                                                                                                                          Alive. BMT                                                                                   ([@B18])
  23 (F4)       UK                      Fem                                                                       2.5                     Microcephaly, psoriasis                              Psoriasis                                                                                                                                                                      Alive                                                                                        ([@B18])
  24 (F5)       USA                     Male                                                                      2                       Microcephaly, hip dysplasia                          Unilateral congenital hip dysplasia.                                                                                                                                           Alive                                                                                        ([@B18])
  25 (F6)       Germany                 Fem                                                                       2                       Microcephaly, hip dysplasia                          Congenital hip dysplasia, 2/3 toe syndactyly, excessive vomiting                                                                                                               Alive                                                                                        ([@B18])
  26 (F7)       USA                     Fem                                                                       3.67                    Microcephaly, growth failure                         None                                                                                                                                                                           Alive                                                                                        ([@B18])
  27 (F8)       UK                      Fem                                                                       1.75                    Microcephaly, growth failure                         None                                                                                                                                                                           Alive                                                                                        ([@B18])
  28 (F9)       Turkey                  Male                                                                      5.5                     Microcephaly, hypopigmentation                       Hypopigmentation, hypermobile knees, single palmar crease, 2/3 toe syndactyly, sandal gap                                                                                      Alive                                                                                        ([@B18])
  29 (P2)       North America           Fem       Sibling to P1 and P3                                            13                      Recurrent pneumonias and sinusitis                   Recurrent respiratory infections, microcephaly, short stature.                                                                                                                 Alive                                                                                        ([@B5])
  30(P1)        North America           Male      Sibling to P2 and P3                                            NA                      NA                                                   One walking pneumonia                                                                                                                                                          Alive                                                                                        ([@B5])
  31 (P3)       North America           Fem       Sibling to P1 and P2                                            NA                      NA                                                   Asymptomatic                                                                                                                                                                   Alive                                                                                        ([@B5])
  32            Belarus                 Fem                                                                       2                       Stomatitis                                           Ulcerated stomatitis, encephalitis, lung and brain lymphoma.                                                                                                                   Died of lymphoma                                                                             ([@B20])
  33 (C1)       African/Asian descent   Fem                                                                       7                       Dysmorphic features, developmental delay             Respiratory infections, pancytopenia                                                                                                                                           Alive and well after HSCT                                                                    ([@B21])
  34 (C2)       Morocco                 Male      Elder sister died at 18 mo. with pancytopenia                   9                       Chronic diarrhea                                     Chronic diarrhea, recurrent respiratory infections, hemorrhagic syndrome                                                                                                       Died of aplasia at age 10                                                                    ([@B21])
  35            Syria                   Fem       Consang.                                                        7                       Dysmorphic features and developmental delay          Recurrent sinopulmonary infections, urosepsis, urofacial syndrome                                                                                                              Died of pneumonia                                                                            ([@B22])
  36            Italy                   Male                                                                      6                       Complicated pneumonia                                Recurrent upper respiratory infections since age 1, dysgammaglobulinemia                                                                                                       Alive                                                                                        ([@B23])
  37 LRL        Mexico                  Fem       Two brothers. 3 first cousins died of infections before age 2   0.75                    Pneumonia at 4 months                                Died of lymphoma                                                                                                                                                               This report                                                                                  
  38 PRL        Mexico                  Male      Two siblings                                                    1.5                     Pneumonia at 12 months                               Died of lymphoma                                                                                                                                                               This report                                                                                  
  39 FRL        Mexico                  Male      Two siblings                                                    1                       Pharyngoamigdal. at 2 months                         Avascular necrosis of femoral head, overweight.                                                                                                                                Alive and well                                                                               This report
  40 MGP        Mexico                  Fem       Twin sister                                                     10                      Recurrent respiratory infections                     Microcephaly, dysmorphism, developmental delay, recurrent infections, jaundice                                                                                                 Died                                                                                         This report
  41 BGP        Mexico                  Fem       Twin sister                                                     10                      Recurrent respiratory infections                     Microcephaly, dysmorphism, developmental delay, recurrent infections, jaundice                                                                                                 Died                                                                                         This report

*NR, Not reported*.

###### 

Key features of published patients with LIG4 deficiency.

  **Patient**   **Micro-cephaly**   **Dysmorphism**                                                                                                                   **Growth failure**   **Developmental delay**                              **Malignancy**                                            **Infections**                                                                            **Bone marrow failure**                         **References**
  ------------- ------------------- --------------------------------------------------------------------------------------------------------------------------------- -------------------- ---------------------------------------------------- --------------------------------------------------------- ----------------------------------------------------------------------------------------- ----------------------------------------------- ------------------------
  1 (180BR)     No                  No                                                                                                                                No                   No                                                   AL Leukemia                                               None                                                                                      No                                              ([@B6], [@B7])
  2             Yes                 Receding forehead, hypertelorism, beaked nose, low set ears, micrognathia, downward palpebral fissures.                           Yes                  Mental retardation, high pitched voice.              AM Leukemia                                               Pneumonia (post chemo)                                                                    Yes (after chemo-therapy)                       ([@B8])
  3 (411BR)     Yes                 Bird-like                                                                                                                         No                   Yes, global                                          Lymphoma (Diffuse large B-cell, nasopharyngeal)           Extensive plantar warts                                                                   Pancytopenia                                    ([@B4], [@B9], [@B10])
  4 (2303)      Yes                 Seckel-like                                                                                                                       Yes                  No                                                   Myelodysplasia                                            Sinusitis                                                                                 Pancytopenia                                    ([@B9])
  5 (2304)      Yes                 Seckel-like                                                                                                                       Yes                  No                                                   None                                                      Chronic respiratory infections                                                            No                                              ([@B9])
  6 (99P0149)   Yes                 Seckel-like, Bird-like                                                                                                            Yes                  Developmental/mental                                 None                                                      Sinopulmonary recurrent                                                                   Pancytopenia, hypoplastic marrow                ([@B9], [@B11])
  7 (3703)      Yes, brachy.        NBS-like                                                                                                                          No                   Yes, significant cognitive delay                     AL Leukemia                                               Neutropenic sepsis after chemo.                                                           Aplasia after chemo.                            ([@B12])
  8 (SC2)       No                  No                                                                                                                                No                   No                                                   None                                                      Recurrent severe respiratory infections, candidiasis in diaper region, chronic diarrhea   Anemia, leukopenia                              ([@B13])
  9 (P2)        Yes                 No                                                                                                                                No                   Yes, significant neurodevelopmental                  None                                                                                                                                                Lymphopenia                                     ([@B14])
  10 (P1)       Yes                 No                                                                                                                                No                   No                                                   Brain and lung non-Hodgkin B cell lymphoma                Sepsis, diarrhea                                                                          Neutropenia, lymphopenia, thrombocytopenia      ([@B14])
  11 (P-1)      Yes                 No                                                                                                                                Yes                  No                                                   None                                                      Otitis, bronchiolitis, pneumonia, sepsis                                                  Lymphopenia                                     ([@B2])
  12 (P-2)      Yes                 No                                                                                                                                No                   No                                                   None                                                      None                                                                                      Lymphopenia                                     ([@B2])
  13            Yes                 No                                                                                                                                Yes                  No                                                   Lymphoma (B-cell, NH) in upper gingiva and hard palate    Pulmonary aspergillosis                                                                   Progressive                                     ([@B15])
  14            Yes                 No                                                                                                                                Yes                  Yes                                                  None                                                      None                                                                                      Marked eosinophilia, mild lymphopenia           ([@B16])
  15            Yes                 Low hairline, prominent nasal bridge, bilateral epicanthi                                                                         Yes                  No                                                   None                                                      Sinopulmonary, ear.                                                                       Pancytopenia, progressive                       ([@B24])
  16            Yes                 Prominent nasal bridge, bilateral epicanthi                                                                                       Yes                  No                                                   None                                                                                                                                                No                                              ([@B24])
  17 (F10)      Yes                 Hypotelorism, small viscerocranium, flat philtrum, thin upper lip, preaxial polydactyly, brachimesophalangy, partial syndactyly   Yes                  Neurologic abnormalities                             None                                                      Urinary tract, sepsis                                                                     Thrombocytopenia                                ([@B17], [@B18])
  18            Yes                 Yes                                                                                                                               NR                   No                                                   Anal cancer                                               None                                                                                      Pancytopenia                                    ([@B18], [@B19])
  19 (F1.1)     Yes                 No                                                                                                                                Yes                  Yes, mild                                            None                                                      Mild. Influenza                                                                           Pancytopenia, self-resolved. Thrombocytopenia   ([@B18])
  20 (F1.2)     Yes                 Malformations                                                                                                                     Yes                  Yes, mild-moderate                                   None                                                      Mild recurrent (respiratory, skin, GI)                                                    Pancytopenia, persistent. Thrombocytopenia      ([@B18])
  21 (F2)       Yes                 Malformation                                                                                                                      Yes                  Yes, mild                                            None                                                      None                                                                                      Pancytopenia, self-resolved. Thrombocytopenia   ([@B18])
  22 (F3)       Yes                 No                                                                                                                                Yes                  Yes, mild                                            None                                                      Mild recurrent (respiratory, skin, GI)                                                    Thrombocytopenia                                ([@B18])
  23 (F4)       Yes                 No                                                                                                                                Yes                  No                                                   None                                                      None                                                                                      Anemia, thrombocytopenia                        ([@B18])
  24 (F5)       Yes                 No                                                                                                                                Yes                  No                                                   None                                                      None                                                                                      Lymphopenia                                     ([@B18])
  25 (F6)       Yes                 Malformations                                                                                                                     Yes                  Yes, mild                                            None                                                      Mild recurrent (respiratory, skin, GI)                                                    Thrombocytopenia                                ([@B18])
  26 (F7)       Yes                 No                                                                                                                                Yes                  No                                                   None                                                      None                                                                                      Thrombocytopenia                                ([@B18])
  27 (F8)       Yes                 No                                                                                                                                Yes                  Yes, mild                                            None                                                      None                                                                                      Thrombocytopenia                                ([@B18])
  28 (F9)       Yes                 Malformations                                                                                                                     Yes                  Yes, mild                                            None                                                      Mild recurrent (respiratory, skin, GI)                                                    Thrombocytopenia                                ([@B18])
  29 (P2)       Yes                 No                                                                                                                                Yes                  No                                                   None                                                      Pneumonia and sinusitis                                                                   Lymphopenia                                     ([@B5])
  30(P1)        unknown             No                                                                                                                                Small stature        None                                                 Walking pneumonia                                         Mild neutropenia                                                                          ([@B5])                                         
  31 (P3)       No                  No                                                                                                                                No                                                                        None                                                      None                                                                                      Lymphopenia, mild neutropenia                   ([@B5])
  32            No                  No                                                                                                                                No                   No                                                   Lymphoma, EBV-pos; diffuse large B-cell; lung and brain   EBV stomatitis/encephalitis                                                               No                                              ([@B20])
  33 (C1)       Yes                 Yes                                                                                                                               Yes                  Yes, mild                                            None                                                      Respiratory                                                                               Slowly progressive pancytopenia                 ([@B21])
  34 (C2)       Yes                 Yes                                                                                                                               Yes                  Severe language delay, moderate mental retardation   None                                                      Respiratory, warts                                                                        Yes                                             ([@B21])
  35            Yes                 Yes                                                                                                                               Yes                  Yes, mild                                                                                                      Pneumonia, otitis media, sinusitis, oral candidiasis. Urosepsis                           Pancytopenia                                    ([@B22])
  36            No                  No                                                                                                                                No                   No                                                   None                                                      Sinopulmonary recurrent, ear                                                              No. Progressive lymphopenia                     ([@B23])
  37 LRL        No                  No                                                                                                                                No                   No                                                   Lung lymphoma                                             Pneumonia 3x                                                                              No                                              This report
  38 PRL        No                  No                                                                                                                                No                   No                                                   Brain B-cell lymphoma (Non-Hodgkin)                       Pneumonia, Perianal ulcers, Sepsis                                                        No                                              This report
  39 FRL        No                  No                                                                                                                                Yes                  No                                                   None                                                      Mild upper respiratory.                                                                   No                                              This report
  40 MGP        Yes                 Yes                                                                                                                               Yes                  Yes                                                  None                                                      Recurrent: sinopulmonary, gastrointestinal, urinary                                       Yes                                             This report
  41 BGP        Yes                 Yes                                                                                                                               Yes                  Yes                                                  None                                                      Recurrent: sinopulmonary, gastrointestinal, urinary                                       Yes                                             This report

*NR, Not reported*.

###### 

Immunological and genetic features of published patients with LIG4 deficiency.

  **Pat**       **Germs (isolates)**                                                                            **Serum immunoglobulins**                  **Other (comment)**                                                                                      **Mutation type**               **Allele 1**                                     **Allele 2**                                     **References**
  ------------- ----------------------------------------------------------------------------------------------- ------------------------------------------ -------------------------------------------------------------------------------------------------------- ------------------------------- ------------------------------------------------ ------------------------------------------------ ------------------------
  1 (180BR)     NR                                                                                              Not reported                               Prophylactic cranial radiation: ulcers, lethargy, tetraparesis                                           hom, miss                       c\. 833 G\>A (p. R278H)                          c\. 833 G\>A (p. R278H)                          ([@B6], [@B7])
  2             NR                                                                                              Not reported                               Chromosomal abberrations. Chemotherapy: severe toxicity                                                  NR                              ND                                               ND                                               ([@B8])
  3 (411BR)     NR                                                                                              Low                                        Microcephaly at birth, not evident at age 9. Null B-cells, low T. T-B-NK+ CID                            hom, miss, (+2 polymorphisms)   c\. 833 G\>A/8 C\>T/26 C\>T (p. R278H/A3V/T9I)   c\. 833 G\>A/8 C\>T/26 C\>T (p. R278H/A3V/T9I)   ([@B4], [@B9], [@B10])
  4 (2303)      NR                                                                                              Not reported                               Hypothyroidism, type 2 diabetes, hypogonadism                                                            comp het, nons                  c\. 1738 C\>T (p.R580X)                          c\. 2440C\>T (p.R814X)                           ([@B9])
  5 (2304)      NR                                                                                              Not reported                               Hypothyroidism, amenorrhea                                                                               comp het, nons                  c\. 1738 C\>T (p.R580X)                          c\. 2440C\>T (p.R814X)                           ([@B9])
  6 (99P0149)   NR                                                                                              All normal                                 Multiple psoriasiform erythrodermic, squamous skin patches, atypical bone maturation, low CD3 and CD19   comp het, miss/nons             c\. 1406 G\>A (p.G469E)                          c\. 2440C\>T (p.R814X)                           ([@B9], [@B11])
  7 (3703)      NR                                                                                              Not reported                               Low birth weight, criptorchidism, hypogonadism, clinodactyly                                             hom, nons                       c.2440C\>T (p.R814X)                             c\. 2440C\>T (p.R814X)                           ([@B12])
  8 (SC2)       Candida                                                                                         Low IgG, IgA and IgM                       T-B-NK+ SCID, reduced lymphoproliferation (PHA, aCD3)                                                    hom, small del                  g.5333_5335delCAA (p. Q433del)                   g.5333_5335delCAA (p. Q433del)                   ([@B13])
  9 (P2)        No                                                                                              Low IgM, absent IgA                        T-B-NK+ SCID, isohemagglutinins present                                                                  comp het, miss/nons             c.1118A\>T (p. H282L)                            c.1544_1548delAAAGA (p.D423fs442X)               ([@B14])
  10 (P1)       S. pneumoniae, HHV6, Norwalk, EBV, Aspergillus                                                  High IgG and IgM, normal IgA               T-B-NK+ SCID, small thymus, autoimmune thrombocytopenia, no tetanus, diphteria or pneumococcus titers    comp het, miss/nons             c.1118A\>T (p. H282L)                            c.1544_1548delAAAGA (p.D423fs442X)               ([@B14])
  11 (P-1)      S. pneumoniae                                                                                   Absent IgA, Low IgG and IgM                T-B-NK+ SCID, reduced lymphoproliferation                                                                comp het, miss/small del        c.1544_1548del5bp (p.K424fs20X)                  c.1112A\>G (p.Q280R)                             ([@B2])
  12 (P-2)      No                                                                                              Low IgM, absent IgA (maternal IgG)         T-B-NK+ SCID, normal lymphoproliferation                                                                 comp het, miss/small del        c.1544_1548del5bp (p.K424fs20X)                  c.1112A\>G (p.Q280R)                             ([@B2])
  13            Aspergillosis after neutropenia                                                                 Low IgM and IgG                            T-B-NK+ CID                                                                                              comp het, miss/small del        c.745A\>G (p.M249V)                              c.1270_1274del5bp (p.K424fs20X)                  ([@B15])
  14            EBV after HSCT                                                                                  Low IgM and IgA                            Low TRECs, B cells, lymphoproliferation, GVHD                                                            comp het, miss/small del        c.845A\>T(p.H282L);c.26C\>T (SNP)                c.1747_1751del5bp (p.R581fsX)                    ([@B16])
  15            NR                                                                                              Low IgM                                    Spontaneous chromosomal breakages increased, normal bone marrow cellularity                              hom, small del                  c.1762delAAG (p.K588del)                         c.1762delAAG (p.K588del)                         ([@B8])
  16                                                                                                            Low IgG and IgM                            Inguinal hernia, spontaneous chromosomal breakage, normal BM cellularity                                 hom, small del                  c.1762delAAG (p.K588del)                         c.1762delAAG (p.K588del)                         ([@B8])
  17 (F10)      P aeruginosa, E faecalis, P jiroveci, rhinovirus, norovirus, astrovirus, C difficile, Candida   Low IgG and B-cells                        Polydactyly, dysplastic kidneys, corpus callosum dysgenesia, very low B-cells                            comp het, SN del trunc/trunc    c.613delT (p.S205LfsX29)                         c\. 1904delA (p.Lys635ArgfsX10)                  ([@B17], [@B18])
  18            No                                                                                              NR                                         Radiotherapy: desquamative skin injury                                                                   comp het, SN del trunc/nons     c.613delT (p.S205LfsX232)                        c.2440C\>T (p.R814X)                             ([@B18], [@B19])
  19 (F1.1)     NR                                                                                              Low IgG                                    Low CD4+, null CD19+                                                                                     comp het, miss/small del        c.2440C\>T (p.R814X)                             c.1271_1275delAAAGA (p.K424RfsX20)               ([@B18])
  20 (F1.2)     NR                                                                                              Low IgG                                    Low CD4+, null CD19+, very low naïve T cells                                                             comp het, miss/small del        c.2440C\>T (p.R814X)                             c.1271_1275delAAAGA (p.K424RfsX20)               ([@B18])
  21 (F2)       NR                                                                                              NR                                         NR                                                                                                       comp het, nons                  c.2440C\>T (p.R814X)                             c.2094C\>G (p.Y698X)                             ([@B18])
  22 (F3)       NR                                                                                              Low IgG                                    Low CD3, CD8, very low CD19                                                                              comp het, dup/nons              c.2440C\>T (p.R814X)                             c.2386_2389dupATTG (p.A797DfsX3)                 ([@B18])
  23 (F4)       NR                                                                                              Low IgG                                    Low CD4+, very low CD19+                                                                                 comp het, nons/small del        c.2440C\>T (p.R814X)                             c.1271_1275delAAAGA (p.K424RfsX20)               ([@B18])
  24 (F5)       NR                                                                                              Low IgG                                    Low CD3, CD4, CD8, very low CD19                                                                         comp het, nons/small del        c.2440C\>T (p.R814X)                             c.1271_1275delAAAGA (p.K424RfsX20)               ([@B18])
  25 (F6)       NR                                                                                              Low IgG                                    Very low CD19+                                                                                           comp het, nons/small del        c.2440C\>T (p.R814X)                             c.1271_1275delAAAGA (p.K424RfsX20)               ([@B18])
  26 (F7)       NR                                                                                              NR                                         NR                                                                                                       comp het, nons/small del        c.2440C\>T (p.R814X)                             c.1512_1513delTC (p.R505CfsX12)                  ([@B18])
  27 (F8)       NR                                                                                              Low IgG                                    NR                                                                                                       comp het, nons/small del        c.2440C\>T (p.R814X)                             c.1246_1250dupGATGC (p.Leu418MetfsX3)            ([@B18])
  28 (F9)       NR                                                                                              Normal                                     Very low CD19+                                                                                           comp het, nons/small del        c.2440C\>T (p.R814X)                             c.1271_1275delAAAGA (p.K424RfsX20)               ([@B18])
  29 (P2)       NR                                                                                              Panhypogammaglobulinemia                   Low CD3+, CD19+, naïve T                                                                                 comp het, miss/nons             c.2440C\>T (p.R814X)                             c.1345A\>C (p.K449Q)                             ([@B5])
  30(P1)        NR                                                                                              Normal IgG                                 Low CD19+, naïve T cells                                                                                 comp het, miss/nons             c.2440C\>T (p.R814X)                             c.1345A\>C (p.K449Q)                             ([@B5])
  31 (P3)       No                                                                                              Low IgG                                    Low CD3+, CD19+, naïve T                                                                                 comp het, miss/nons             c.2440C\>T (p.R814X)                             c.1345A\>C (p.K449Q)                             ([@B5])
  32            EBV                                                                                             Low IgA                                    Low T cells                                                                                              comp het, small del/miss        c.2736+3delC                                     c.8C\>T (p.A3V); c.26C\>T(p.T9I)                 ([@B20])
  33 (C1)       NR                                                                                              Low IgG and IgM                                                                                                                                     comp het, nons/small del        c.2440C\>T (p.R814X)                             c.1271_1275delAAAGA (p.K424RfsX20)               ([@B21])
  34 (C2)       HPV                                                                                             NR                                                                                                                                                  comp het, miss/small del        c.847A\>G (p.K283E)                              c.1271_1275delAAAGA (p.K424RfsX20)               ([@B21])
  35            S. pneumoniae, H. influenzae                                                                    Low IgG2 and IgM                           Low CD4+, null CD19+. Urofacial syndrome with hom. LRIG2 mut.                                            hom, miss                       c.T1312C (p.Y438H)                               c.T1312C (p.Y438H)                               ([@B22])
  36            NR                                                                                              Absent IgA and IgM. Normal IgG, low IgG3   Very low T and B cells. Poor response to vaccines. Bronchiectasis                                        comp het, miss/small del        c\. 833 G\>A (p. R278H)                          c.1271_1275delAAAGA (p.K424RfsX20)               ([@B23])
  37 LRL        Acinetobacter baumanii, Enterococcus faecium, Enterobacter aerogenes, CMV                       All normal                                 Low T cells                                                                                              NR                              ND                                               ND                                               This report
  38 PRL        Pseudomonas, CMV                                                                                All normal                                 Low T cells                                                                                              NR                              ND                                               ND                                               This report
  39 FRL        No                                                                                              All normal                                 Legg-Calvé-Perthes disease, right hip. Low CD4+, low lymphoproliferation.                                comp het, miss                  c.1236T\>A (p.N412K)                             c.32C\>G (p.A11G)                                This report
  40 MGP        NR                                                                                              Low IgG, IgA and IgM                       Primary amenorrhea, sclerosing cholangitis                                                               comp het, small del/miss        c.1271_1275delAAAGA (p.K424RfsX20)               c.745A\>G (p.M249V)                              This report
  41 BGP        NR                                                                                              Low IgG, IgA and IgM                       Primary amenorrhea, sclerosing cholangitis                                                               NR                              ND                                               ND                                               This report

*ND, Not done; NR, Not reported; NT, Not tested; IR, ionizing radiation; BLM, bleomycin; DEB, diepoxybutane; MITC, mitomycin C. All reported mutations are hypomorphic*.

###### 

Prevalence of clinical and laboratory features found in 41 LIG4 deficiency patients.

  ---------------------------- ------- -----
  Female                       28/41   68%
  Microcephaly                 32/40   80%
  Dysmorphic facial features   15/41   37%
  Growth failure               28/40   70%
  Syndactyly/Polysindactyly    4/41    10%
  Other malformations          3/41    7%
  Congenital hip dysplasia     4/41    10%
  Infections (any)             28/41   68%
  Sinopulmonary infections     23/41   56%
  Skin conditions              8/41    20%
  Warts                        2/41    5%
  Hypogammaglobulinemia        25/30   83%
  Very low CD19+ B-cells       24/30   80%
  Malignancy                   10/41   24%
  Bone marrow failure          17/39   44%
  Radiosensitivity             24/28   86%
  ---------------------------- ------- -----

*(100% radiosensitivity with ionizing radiation)*.

Discussion {#s4}
==========

We describe a series of five LIG4 deficiency patients with a wide spectrum of clinical manifestations, ranging from short stature and asymptomatic CD4+ lymphopenia, to liver failure with sudden massive bleeding.

Although relatively small, this is one of the largest case series to date on the subject of LIG4 deficiency; the genetic diagnosis was confirmed in both families by whole-exome sequencing only, but we also reviewed the literature for all published patients to date (our job was aided by a recent review by Altmann and Gennery ([@B1]) comprising 28 LIG4 deficient patients up until 2016).

Forty-one LIG4 deficiency patients have been described to date (In addition, Bluteau et al. recently found three cases of LIG4 deficiency among their cohort of bone marrow failure patients, although their features were not described in detail) ([@B25]). Their phenotypes are varied, with more clinical severity associated to early mutations and a truncated protein. The degree of severity is probably linked to the amount of residual function of the ligase, but confounded by the complex interactions and the intricate redundancy of the DNA repair defect machinery.

To our knowledge, our patients from family B are the first to develop sclerosing cholangitis (SC) in the context of LIG4 deficiency. SC has been reported mainly in X-linked Hyper-IgM syndrome due to CD40L deficiency, but also in other forms of combined immunodeficiencies ([@B26]). This autoimmune complication is thought to result from the colonization of the bile ducts by Cryptosporidium and microsporidium from the small intestine, eventually leads to biliary cirrhosis and liver failure, which greatly complicates prognosis. SC should be considered in patients with lymphocyte defects and cholestatic jaundice. All such patients should be warned against drinking unpurified water, and against having close contact with dog pets.

When there is a full-blown phenotype of combined immunodeficiency, we can fear the complications of malignancy and bone marrow failure. In contrast, it is unclear what the best approach is with asymptomatic patients carrying a deleterious variant in *LIG4*. In theory, they will accumulate DNA double-strand breaks and cell damage that result in increased apoptosis of hematopoietic cells, with the consequent risk of late-onset aplastic anemia and malignancy. Felgentreff et al. ([@B5]) recently reported immunological findings in two asymptomatic siblings who shared a *LIG4* bi-allelic mutation (K449Q/R814X) with their sister (the proband), but not a history of infections; all three siblings with compound heterozygous mutations had: low mean corpuscular volume, B-cell lymphopenia, shortened telomeres, reduced naïve T-cells, and increased radiosensitivity, as well as some skewing of their lymphocytes\' receptor repertoires. The immune defects are thus present but clinically silent, and environmental or infectious triggers might precipitate bone marrow failure or myelodysplasia.

The differential diagnosis of LIG4 deficiency includes Nijmegen Breakage Syndrome (NBS), RAD50 and NHEJ1 deficiencies; Fanconi anemia, and any other congenital disease presenting with: microcephaly, facial dysmorphisms (described as bird-like facies); hypogammaglobulinemia, and low B-cells; including IKAROS and NFKB2 deficiencies. Dubowitz and Seckel\'s are clinical syndromes of which LIG4 deficiency patients undoubtedly represent a considerable subset of cases ([@B19]). Of note, LIG4 deficient patients may first seek medical care for hematologic malignancies, but respond badly to chemotherapy and radiotherapy; the astute clinician should consider this diagnosis in patients with suggestive clinical features ([@B12]), and consider instead hematopoietic stem-cell transplantation (HSCT) after a reduced intensity conditioning (RIC) regime.

Not all patients have had microcephaly, but all had radiosensitivity when their cell cultures were exposed to ionizing gamma radiation. Our twin sisters\' cells were reported normal or negative for the bleomycin (BLM) radiomimetic test, which has been described to have a strong positive correlation when compared to ionizing radiation with gamma rays. However, it has also been found to be more selective and less predictable than gamma radiation ([@B27]--[@B29]). BLM is an antibiotic obtained from *Streptomyces verticillus*, used in the treatment of cancer and considered a radiomimetic for its induction of single and double DNA strand breaks, in the presence of iron ions in cell cultures ([@B27]).

Given the dreaded fatal complications of hematologic neoplasia, bone marrow failure and chronic liver disease, the best chance LIG4-deficient patients with severe (hematological/immunological) phenotypes have of reaching adulthood, might be to receive an HSCT ([@B11], [@B30]) under the best possible conditions (HLA-identical donor, a reduced intensity conditioning regime with low-dose Cyclosporin A ([@B24], [@B30], [@B31]), infection-free, no organ failure). The neurological deficits and mental retardations are usually mild enough to allow for a happy and productive life in transplant survivors, capable of loving and being loved, and of learning a craft.

In conclusion, LIG4 deficient patients may present soon after birth or later in life, with, or without: a family history of consanguinity and affected siblings, microcephaly, beaked nose, T-B-NK+ SCID, Omenn syndrome, low serum immunoglobulins, and very low B-cells, worsening pancytopenia, radiosensitivity; and they may develop bone marrow failure, sepsis, severe bleeding, and/or hematologic malignancies. Early diagnosis is crucial, as hematologic and infectious complications are more frequent with increasing age, and because RIC HSCT may be curative.
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:   Mexico
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